from Belgium reported 7 patients carrying MAN1B1 gene mutations and classified these cases as congenital glycosylation type II disorder (CDG-II), suggesting that MAN1B1 gene mutations may be a potential pathogenic factor (2, 3). This evidence concerns the gene MAN1B1 and ALG2-congenital disorder of glycosylation.